Cargando…
Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Uveal Melanoma (UM) is a rare and malignant intraocular tumor with dismal prognosis. Despite the efficient control of the primary tumor by radiation or surgery, up to 50% of patients subsequently develop metastasis, mainly in the liver. Once the tumor has spread from the eye, the treatment is challe...
Autores principales: | Vivet-Noguer, Raquel, Tarin, Malcy, Roman-Roman, Sergio, Alsafadi, Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678734/ https://www.ncbi.nlm.nih.gov/pubmed/31330784 http://dx.doi.org/10.3390/cancers11071019 |
Ejemplares similares
-
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
por: Tarin, Malcy, et al.
Publicado: (2023) -
Glycolysis Dependency as a Hallmark of SF3B1-Mutated Cells
por: Vivet-Noguer, Raquel, et al.
Publicado: (2022) -
Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution
por: Canbezdi, Christine, et al.
Publicado: (2021) -
Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model
por: Fornabaio, Giulia, et al.
Publicado: (2018) -
Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers
por: Alsafadi, Samar, et al.
Publicado: (2020)